We are delighted to announce the appointment of Dustin Reibe as Director, Clinical Services with Re:Cognition Health.
In his new role, Dustin is responsible for the leadership and development of Re:Cognition Health’s private patient and medicolegal business and looks forward to further developing and expanding Re:Cognition’s award-winning neurological and neuro-psychiatric specialist services for acquired, traumatic, developmental, and neurodegenerative conditions affecting the brain and mind.
Dustin will be expanding Re:Cognition’s existing services for all ages, from young children with autism to the older population with Alzheimer’s. In addition, he will be leading the introduction of Re:Cognition Health’s new Medicinal Cannabis and Long Covid Clinics.
Commenting on his appointment, Dustin said, “Re:Cognition Health’s vision to change the future of Brain and Mind Health is inspirational and I am thrilled to be in a unique position, at the forefront of innovation in brain and mind services, for the future.
Cognitive health is an increasingly significant health priority, due to the UK’s aging demographic and individual lifestyle choice, for a healthy brain and mind, at all ages. My goal is to expand Re:Cognition’s footprint within the UK and position the company to meet future demands. I am looking forward to working with incredible clinicians, partners and private medical insurers.”
Dr Emer MacSweeney, Founder & CEO of Re:Cognition Health said, “we are delighted Dustin has joined our energetic and forward-thinking team. This is an extremely exciting time, worldwide, for new biomarkers and medications for diseases affecting the brain and mind. The rate of change and process in this challenging arena of healthcare has never been more rapid. It is a great time for the company to welcome an individual with Dustin’s commercial healthcare knowledge, operational skills, and entrepreneurial experience.
We are also delighted with the process delivered by Linda Stock, Head of Practice at Carter Schwartz.”